Paydirt
AS
Insider

Andrew J. Schwab

Director · CAMP4 THERAPEUTICS

Andrew J. Schwab (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
Sep 23
Filed Sep 24

Median ADV $1.1M across their filed names

Open performance→
Volume by month
$2.5M$1.2M$0Dec 2024Jun 2025Dec 2025Jun 2026Jul 2025 · sells $777KAug 2025 · sells $770KAug 2026 · sells $2.5MSep 2026 · sells $185K
Buys $0 Sells $4.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
CAMP CAMP4 THERAPEUTICS CORPORATION CAMP · 0 buys · 2 sells 2 filings SKYE Skye Bioscience, Inc. SKYE · 0 buys · 2 sells 2 filings TRDA Entrada Therapeutics, Inc. TRDA · 0 buys · 1 sell 1 filing
Recent filings
SKYESALE Skye Bioscience, Inc. View filing → $185K
114,851 sh × $1.61
Exec Sep 23
Filed Sep 24 · 4:31 PM ET CAMPSALE CAMP4 THERAPEUTICS CORPORATION View filing → $1.6M
400,000 sh × $4.04
Exec Aug 27
Filed Aug 31 · 5:05 PM ET CAMPSALE CAMP4 THERAPEUTICS CORPORATION View filing → $880K
191,865 sh across 3 lots
Exec Aug 19
Filed Aug 21 · 4:59 PM ET SKYESALE Skye Bioscience, Inc. View filing → $770K
222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. View filing → $777K
112,156 sh across 4 lots
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET